Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush
Nov 10, 2024
Biopharma Invest Information
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma
Apr 29, 2024
MindMed's Strategic Shift in 2024: Focusing on Anxiety Treatments and Halting LSD Microdosing for ADHD
Jan 11, 2024
FATE Therapeutics Posts Strong Q3 Results; Stocks of Related Biopharma Companies Analyzed
Nov 9, 2023